Literature DB >> 21420691

Anxiety and depression severity are related to right but not left onset Parkinson's disease duration.

Paul S Foster1, Valeria Drago, Gregory P Crucian, William K Sullivan, Robert D Rhodes, Brian V Shenal, Barry Skoblar, Frank M Skidmore, Kenneth M Heilman.   

Abstract

Depression and anxiety have both been associated with relative left frontal hypoactivation and the motor symptoms of Parkinson's disease typically begin in a lateral or asymmetrical fashion. Hence, PD patients with right hemibody onset may experience heightened depression and anxiety. However, research is mixed regarding whether right or left hemibody onset PD is associated with elevated levels of depression and anxiety. This literature, though, has not considered the potential moderating variable of disease duration. We hypothesized that disease duration would be positively correlated with measures of depression and anxiety in right but not left hemibody onset PD patients. The results indicated that scores on the Geriatric Depression Scale, Beck Depression Inventory-II, and the State Trait Anxiety Scale - State correlated positively with disease duration, but only in the right hemibody onset group of PD patients. Thus, right hemibody onset PD is associated with more severe depressive and anxiety symptoms, but only when disease duration is considered.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21420691     DOI: 10.1016/j.jns.2011.02.023

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

Review 1.  Systematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.

Authors:  Atami Sagna; Joseph J Gallo; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2014-04-01       Impact factor: 4.891

2.  Impaired long contact white matter fibers integrity is related to depression in Parkinson's disease.

Authors:  Jia-Yong Wu; Yang Zhang; Wen-Bo Wu; Gang Hu; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2017-11-10       Impact factor: 5.243

3.  Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson's Disease.

Authors:  Sarah M Szymkowicz; Vonetta M Dotson; Jacob D Jones; Michael S Okun; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2017-10-16       Impact factor: 2.892

4.  Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study.

Authors:  Roberto Erro; Sabina Pappatà; Paolo Barone; Maria Teresa Pellecchia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-12-07       Impact factor: 9.236

5.  Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depression.

Authors:  Richard B Dewey; Aanchal Taneja; Shawn M McClintock; C Munro Cullum; Richard B Dewey; Ira Bernstein; Mustafa M Husain
Journal:  Cogn Behav Neurol       Date:  2012-09       Impact factor: 1.600

6.  The Natural History of Depression in Parkinson's Disease within 30-Month Follow-Up.

Authors:  Yuan-Yuan Xu; Sheng-Han Kuo; Zheng Liang; Hui Xu; Wu-Ruo Feng; Cui-Yu Yu; Wei-Guo Liu
Journal:  Parkinsons Dis       Date:  2015-02-01

Review 7.  Neural and behavioral substrates of subtypes of Parkinson's disease.

Authors:  Ahmed A Moustafa; Michele Poletti
Journal:  Front Syst Neurosci       Date:  2013-12-24

8.  Cognitive Function in Parkinson's Disease Patients with and without Anxiety.

Authors:  K A Ehgoetz Martens; J Y Y Szeto; A J Muller; J M Hall; M Gilat; C C Walton; S J G Lewis
Journal:  Neurol Res Int       Date:  2016-10-09

9.  Side-of-onset of Parkinson's disease in relation to neuropsychological measures.

Authors:  Edward J Modestino; Chioma Amenechi; AnnaMarie Reinhofer; Patrick O'Toole
Journal:  Brain Behav       Date:  2016-10-19       Impact factor: 2.708

Review 10.  Disruption of Inferior Longitudinal Fasciculus Microstructure in Parkinson's Disease: A Systematic Review of Diffusion Tensor Imaging Studies.

Authors:  Maryam Haghshomar; Mahsa Dolatshahi; Farzaneh Ghazi Sherbaf; Hossein Sanjari Moghaddam; Mehdi Shirin Shandiz; Mohammad Hadi Aarabi
Journal:  Front Neurol       Date:  2018-07-26       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.